These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 26626260)
1. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. Mitsui Y; Chang I; Fukuhara S; Hiraki M; Arichi N; Yasumoto H; Hirata H; Yamamura S; Shahryari V; Deng G; Wong DK; Majid S; Shiina H; Dahiya R; Tanaka Y BMC Cancer; 2015 Dec; 15():942. PubMed ID: 26626260 [TBL] [Abstract][Full Text] [Related]
2. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Chang I; Mitsui Y; Fukuhara S; Gill A; Wong DK; Yamamura S; Shahryari V; Tabatabai ZL; Dahiya R; Shin DM; Tanaka Y Oncotarget; 2015 Apr; 6(10):7774-87. PubMed ID: 25860934 [TBL] [Abstract][Full Text] [Related]
3. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke. Ishida M; Mikami S; Shinojima T; Kosaka T; Mizuno R; Kikuchi E; Miyajima A; Okada Y; Oya M Int J Cancer; 2015 Jul; 137(2):299-310. PubMed ID: 25523818 [TBL] [Abstract][Full Text] [Related]
4. MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Redova M; Poprach A; Besse A; Iliev R; Nekvindova J; Lakomy R; Radova L; Svoboda M; Dolezel J; Vyzula R; Slaby O Tumour Biol; 2013 Feb; 34(1):481-91. PubMed ID: 23150176 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475 [TBL] [Abstract][Full Text] [Related]
6. STAT3 regulates miR93-mediated apoptosis through inhibiting DAPK1 in renal cell carcinoma. Du Y; Kong C Cancer Gene Ther; 2021 May; 28(5):502-513. PubMed ID: 33230258 [TBL] [Abstract][Full Text] [Related]
7. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma. Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839 [TBL] [Abstract][Full Text] [Related]
8. Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma. Song Z; Li Z; Han W; Zhu C; Lou N; Li X; Luo G; Peng S; Li G; Zhao Y; Guo Y Aging (Albany NY); 2020 Nov; 13(2):1842-1858. PubMed ID: 33201837 [TBL] [Abstract][Full Text] [Related]
9. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma. Chen D; Zhu M; Su H; Chen J; Xu X; Cao C J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453 [TBL] [Abstract][Full Text] [Related]
10. ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway. Zhang G; Yu Z; Fu S; Lv C; Dong Q; Fu C; Kong C; Zeng Y Cancer Gene Ther; 2019 Sep; 26(9-10):323-333. PubMed ID: 30459398 [TBL] [Abstract][Full Text] [Related]
11. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells. Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma. Zhang M; Lu W; Huang Y; Shi J; Wu X; Zhang X; Jiang R; Cai Z; Wu S J Mol Histol; 2016 Aug; 47(4):421-8. PubMed ID: 27323757 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells. Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977 [TBL] [Abstract][Full Text] [Related]
14. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
15. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115 [TBL] [Abstract][Full Text] [Related]
16. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes. Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1. Tong Z; Meng X; Wang J; Wang L Mol Med Rep; 2018 Jan; 17(1):1361-1367. PubMed ID: 29115609 [TBL] [Abstract][Full Text] [Related]
18. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition. Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807 [TBL] [Abstract][Full Text] [Related]
19. Expression and functional role of miR-29b in renal cell carcinoma. Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729 [TBL] [Abstract][Full Text] [Related]